Search Results

0 results for 'Sanofi US Services'

You can use to get even better search results
October 09, 2024 | Law.com

GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B

The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.
4 minute read
October 04, 2024 | Texas Lawyer

4 Law Firms Back Texas AG Suit on Insulin Price-Gouging Allegations

The state alleges this insulin pricing scheme violates the Texas Deceptive Trade Practices Act, constitutes unjust enrichment, and represents an unlawful civil conspiracy.
4 minute read
September 20, 2024 | National Law Journal

FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices

"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed," said Rahul Rao, deputy director of the FTC's Bureau of Competition.
6 minute read
September 04, 2024 | Connecticut Law Tribune

Lawsuit Linking Zantac to Cancer Diagnoses Survives Fight Over Jurisdiction

Waterbury Superior Court Judge W. Glen Pierson ruled that defendants, having registered to do business in Connecticut, consented to the jurisdiction of the state's courts.
4 minute read
August 02, 2024 | Corporate Counsel

Fast-Growing Madrigal Pharma Names Veteran Health Care Lawyer Legal Chief

The Pennsylvania-based company promoted Shannon Kelley to her first general counsel post, just months after the successful launch of a drug to treat liver disease
3 minute read
July 29, 2024 | Connecticut Law Tribune

Hundreds of Plaintiffs Deploy Litigation Strategy in Zantac Suits

"Juries can be fickle, and if you have to try nine cases nine times, you may get nine different results," Peter Bowman, a personal injury lawyer for BBB Attorneys, said.
3 minute read
June 27, 2024 | Law.com

AstraZeneca Sues an Attorney General as Big Pharma Challenges Rise

"Exploiting a loophole in the federal 340B drug program—a program intended to benefit the needy—[pharmaceutical companies] have in recent years begun imposing their will on Mississippi medical providers and pharmacies," the defendant contended.
4 minute read
June 17, 2024 | Law.com

The Real Impact of the Biden Era on M&A

"Changes in the merger review process has undoubtedly increased the cost and resource burden on merging parties," write Elizabeth Suarez, Kaylynn Moss and Terry Calvani.
13 minute read
June 14, 2024 | Law.com

After Federal Judge's Dismissal, Zantac Legal Fight Reignites in State Courts

On May 23, the first verdict in the nation over Zantac came out in Illinois, while a Delaware judge's May 31 decision allowed plaintiffs' experts for thousands of cases.
7 minute read
June 12, 2024 | Delaware Business Court Insider

Zantac Defendants: Delaware Could See Mass Tort Surge If Expert Testimony Decision Holds

"The resulting influx of cases could have significant consequences for the efficient administration of justice in Delaware, for both Delaware-domiciled companies and Delaware residents," the defendants said in the application for interlocutory review.
4 minute read

Resources

  • Strong & Hanni Solves Storage Woes--Learn How You Can, Too

    Brought to you by Filevine

    Download Now

  • Meeting the Requirements of California's SB 553: Workplace Violence Prevention

    Brought to you by NAVEX Global

    Download Now

  • The Benefits of Outsourcing Beneficial Ownership Information Filing

    Brought to you by Wolters Kluwer

    Download Now

  • The Top 10 AI Use Cases in Private Equity

    Brought to you by Ontra

    Download Now